TY - JOUR
T1 - Response to
T2 - "consideration of KRAS Mutation Status May Enhance the Prognostic Impact of Indeterminate Extrahepatic Disease in the Lungs, as Identified by 18FDG-PET, in Patients with Colorectal Liver Metastases"
AU - Wong, Geoffrey Yuet Mun
AU - Kumar, Rajiv
AU - Beeke, Carol
AU - Ullah, Shahid
AU - Chen, John
AU - Karapetis, Christos S.
AU - Price, Timothy J.
AU - Padbury, Rob
PY - 2018/7/1
Y1 - 2018/7/1
N2 - We would like to thank Dr. Margonis and colleagues for their response to our article and considerate comments. Our study had demonstrated that indeterminate extrahepatic disease in the lungs, as identified by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography had a predictive value in identifying patients at risk for site-specific recurrence.1 In their response, Margonis and colleagues had proposed the integration of Kirsten Rat Sarcoma (KRAS) mutation status to improve the prognostic impact of indeterminate colorectal lung metastases in patients being considered for resection of colorectal liver metastasis.
AB - We would like to thank Dr. Margonis and colleagues for their response to our article and considerate comments. Our study had demonstrated that indeterminate extrahepatic disease in the lungs, as identified by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography had a predictive value in identifying patients at risk for site-specific recurrence.1 In their response, Margonis and colleagues had proposed the integration of Kirsten Rat Sarcoma (KRAS) mutation status to improve the prognostic impact of indeterminate colorectal lung metastases in patients being considered for resection of colorectal liver metastasis.
UR - http://www.scopus.com/inward/record.url?scp=85018510207&partnerID=8YFLogxK
U2 - 10.1097/SLA.0000000000002266
DO - 10.1097/SLA.0000000000002266
M3 - Letter
C2 - 28426481
AN - SCOPUS:85018510207
SN - 0003-4932
VL - 268
SP - e9-e10
JO - Annals of Surgery
JF - Annals of Surgery
IS - 1
ER -